Egf Theramed Health Stock Net Income

EVAHF Stock  USD 0.04  0.00  0.00%   
As of the 14th of February 2026, EGF Theramed shows the mean deviation of 2.79, and Standard Deviation of 10.86. EGF Theramed Health technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm EGF Theramed Health mean deviation, variance, as well as the relationship between the Variance and maximum drawdown to decide if EGF Theramed Health is priced some-what accurately, providing market reflects its regular price of 0.043 per share. As EGF Theramed Health appears to be a penny stock we also advise to verify its information ratio numbers.
EGF Theramed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing EGF Theramed's valuation are provided below:
EGF Theramed Health does not right now have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
It's important to distinguish between EGF Theramed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EGF Theramed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, EGF Theramed's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

EGF Theramed 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to EGF Theramed's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of EGF Theramed.
0.00
11/16/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/14/2026
0.00
If you would invest  0.00  in EGF Theramed on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding EGF Theramed Health or generate 0.0% return on investment in EGF Theramed over 90 days. EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health More

EGF Theramed Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure EGF Theramed's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess EGF Theramed Health upside and downside potential and time the market with a certain degree of confidence.

EGF Theramed Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for EGF Theramed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as EGF Theramed's standard deviation. In reality, there are many statistical measures that can use EGF Theramed historical prices to predict the future EGF Theramed's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.0411.43
Details
Intrinsic
Valuation
LowRealHigh
0.000.0411.43
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as EGF Theramed. Your research has to be compared to or analyzed against EGF Theramed's peers to derive any actionable benefits. When done correctly, EGF Theramed's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in EGF Theramed Health.

EGF Theramed February 14, 2026 Technical Indicators

EGF Theramed Health Backtested Returns

At this point, EGF Theramed is out of control. EGF Theramed Health secures Sharpe Ratio (or Efficiency) of close to zero, which denotes the company had a close to zero % return per unit of return volatility over the last 3 months. We have found sixteen technical indicators for EGF Theramed Health, which you can use to evaluate the volatility of the firm. Please confirm EGF Theramed's standard deviation of 10.86, and Mean Deviation of 2.79 to check if the risk estimate we provide is consistent with the expected return of 0.0391%. The firm shows a Beta (market volatility) of 0.23, which means not very significant fluctuations relative to the market. As returns on the market increase, EGF Theramed's returns are expected to increase less than the market. However, during the bear market, the loss of holding EGF Theramed is expected to be smaller as well. EGF Theramed Health at this time shows a risk of 11.29%. Please confirm EGF Theramed Health variance, as well as the relationship between the maximum drawdown and rate of daily change , to decide if EGF Theramed Health will be following its price patterns.

Auto-correlation

    
  -0.19  

Insignificant reverse predictability

EGF Theramed Health has insignificant reverse predictability. Overlapping area represents the amount of predictability between EGF Theramed time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of EGF Theramed Health price movement. The serial correlation of -0.19 indicates that over 19.0% of current EGF Theramed price fluctuation can be explain by its past prices.
Correlation Coefficient-0.19
Spearman Rank Test0.48
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, EGF Theramed Health reported net income of (1.35 Million). This is 100.4% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The net income for all United States stocks is 100.24% higher than that of the company.

EGF Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EGF Theramed's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of EGF Theramed could also be used in its relative valuation, which is a method of valuing EGF Theramed by comparing valuation metrics of similar companies.
EGF Theramed is currently under evaluation in net income category among its peers.

EGF Fundamentals

About EGF Theramed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze EGF Theramed Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EGF Theramed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EGF Theramed Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in EGF Pink Sheet

EGF Theramed financial ratios help investors to determine whether EGF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EGF with respect to the benefits of owning EGF Theramed security.